Creative Biolabs has announced an integrated approach to custom oligosaccharide synthesis and glycan characterization, aiming to support researchers in glycan-based therapeutics, vaccines, and biomarker studies. The company combines advanced chemical, enzymatic, and chemoenzymatic synthesis technologies with comprehensive analytical platforms, including mass spectrometry (MS), high-performance liquid chromatography (HPLC), and nuclear magnetic resonance (NMR), to deliver structurally defined oligosaccharides.
Oligosaccharides play critical roles in cell signaling, immune regulation, pathogen-host interactions, and disease progression, making them valuable for therapeutic, vaccine, and diagnostic research. However, their structural complexity complicates synthesis, purification, and characterization. Creative Biolabs addresses these challenges by offering custom synthesis of high-purity oligosaccharides, complex glycans, tumor-associated carbohydrate antigens (TACAs), and functionalized carbohydrate derivatives, followed by rigorous analytical validation.
“The structural complexity of oligosaccharides continues to present significant challenges for researchers developing next-generation therapeutics,” said a scientist from Creative Biolabs. “By integrating custom synthesis with comprehensive analytical characterization, we help researchers obtain structurally validated glycans that support reliable downstream studies and accelerate scientific discovery.”
Researchers utilizing these services have reported benefits in downstream structural confirmation. In one recent project, a complex glycan structure not readily available from commercial sources was successfully synthesized and characterized using the integrated platform. The company’s application-oriented carbohydrate design supports diverse fields including structural biology, glycoprotein research, biomarker discovery, immunology, targeted drug delivery, and therapeutic development.
By combining custom carbohydrate synthesis with rigorous analytical characterization under one integrated platform, Creative Biolabs helps reduce technical risks, improve experimental reproducibility, and support more efficient project progression. Researchers can explore customized oligosaccharide synthesis and glycan characterization options through Creative Biolabs' glycobiology platform at https://www.creative-biolabs.com/glycoprotein/.
